Clinical trial

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT03118765

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention GSP304 (tiotropium bromide) Inhalation Solution Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention GSP304 Placebo Inhalation Solution Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Spiriva® Respimat® inhalation spray Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-03-24

PhasePHASE2

Conditions

Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)unresolved

Interventions

GSP304 (tiotropium bromide) Inhalation SolutionDRUG

GSP304 Placebo Inhalation SolutionDRUG

Spiriva® Respimat® inhalation sprayDRUG

Sponsors & collaborators

Glenmark Specialty S.A.lead sponsor

Mapped research locations

MiamiFlorida, United States2 ColumbusOhio, United States2 GreenvilleSouth Carolina, United States2 SpartanburgSouth Carolina, United States2 PhoenixArizona, United States1 OrlandoFlorida, United States1 Las VegasNevada, United States1 CharlotteNorth Carolina, United States1 MedfordOregon, United States1 FullertonCalifornia, United States1 Winter ParkFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03118765 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.